| Dear E, To fully realize all the advantages and benefits of a decentralized approach to clinical trials, partnering with a reliable and experienced CRO to implement and execute your decentralized solution is critical. At Rho, our experts have a demonstrated track record of success deploying customized, patient-centric solutions that ensure trial and data integrity. We’ve created a case study to share how we guided a mid-sized biotech company that was in the middle of conducting an open-label long-term safety study when the COVID-19 pandemic hit. This case study shares how we used our risk assessment process to create a hybrid decentralized solution based on unique site variables. Implemented solutions included: Telemedicine Visits Home Health Care Visits Local Lab Visits Direct to Patient IP Shipments Monitoring Solutions Updated Study Documents and Systems | 